Issue 17

CDMO Market Set for Unprecedented Growth Across Pharmaceuticals, Antibodies & Recombinant Proteins

Why not sign up for our future email newsletters? Sign up here.

Included in this issue:

LEAD STORY

CDMOs on the Rise: Powering the Future of Biopharma and Pharma with Unstoppable Growth

Recently published reports (from The Brainy Insights & InsightAce Analytic Pvt. Ltd) suggest the CDMO industry is poised for significant growth that will continue into the next decade. 

Read more here.

FEATURED STORIES

Fujifilm Diosynth Opens New Microbial Manufacturing Facility in the UK

Read more here.

Touchlight to Provide GMP dbDNA for Zika Virus Vaccine Clinical Study

Read more here.

WuXi Secures New US Contracts Despite Biosecurity Concerns

Read more here.

Bora Makes Strategic Investment in Tanvex to Combine Biomanufacturing

Read more here.

ST Pharm and Quantoom Biosciences Expand Collaboration to Advance RNA Manufacturing

Read more here.

VXGI Joins BioMAP for Biopharma Manufacturing Preparedness

Read more here.

Scorpius Holdings Reports 16% Revenue Growth in Q2 2024

Read more here.

Lexaria’s GLP-1 Study Shows Promising 8-Week Weight Loss Results 

Read more here.

Bora Completes Emergent Fill-Finish Facility Deal

Read more here.

FDA Clears Immpact Bio’s CAR-T MS Therapy

Read more here.

Eli Lilly Embraces Oblique Antibody Discovery for New High-Value Targets

Read more here.

Everest Medicines Launches IIT for Personalized mRNA Cancer Vaccine

Read more here.